Exhibitor Product Theater - From Diagnosis to Treatment: Assessing Moderately to Severely Active Crohn's Disease

Anita Afzali, MD, MPH, MHCM, FACG

This program is sponsored by Takeda Pharmaceuticals U.S.A., Inc.

An interactive case study discussing a hypothetical Crohn’s disease patient. This case will cover patient presentation, biomarker and imaging findings, treatment options, and follow-up.

Open to all ACG 2022 attendees, industry-sponsored Product Theater provide additional educational opportunities. These programs are independent of the ACG 2022 Annual Scientific Meeting and Postgraduate Course programs. No CME is provided for Exhibit Product Theater presentations.